X

PRE

Prenetics Reports Record Q4 and FY2025 Revenue; Guides for 2026 Growth

Prenetics Global Limited (NASDAQ: PRE), a health sciences company, reported record financial results for the fourth quarter and full fiscal…

Prenetics CEO On Genetic Testing Evolution

Danny Yeung, CEO of Prenetics, discusses the evolution of consumer genetic testing and the company's growth strategy. On Market Evolution…